14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
INEO vs SNYR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, INNEOVA Holdings Limited (INEO) is the stronger overall head-to-head candidate over Synergy CHC Corp. (SNYR) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). INEO carries a Unified Composite Score of 41.3/100 (SELL) at $0.49 (N/M Forward P/E, -0.8% operating margin), whereas SNYR carries 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin).
Composite vs. Pillar Nuance: While SNYR currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. INEO 41.3/100 SELL), INEO captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-0.8% vs. -10.3% operating margin) and revenue trajectory (-16.2% vs. -32.8% YoY).
Technical & Structure Timing Caution: INEO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.0); meanwhile SNYR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on INEO vs SNYR. Trailing 12-month operating profitability (INEO -0.8% vs SNYR -10.3%) and valuation multiples (INEO N/M vs SNYR 0.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Distribution value chain with $4.1M market capitalization and -10.3% operating margin.
OpEx & R&D Reinvestment75.7% of Rev ($21M)
90D Engineering Disclosures0 Published
Investor FAQ INEO vs SNYR Key Questions & Quantitative Answers
As of Nov 20, 2026, INNEOVA Holdings Limited (INEO) is the stronger overall head-to-head candidate over Synergy CHC Corp. (SNYR) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). INEO carries a Unified Composite Score of 41.3/100 (SELL) at $0.49 (N/M Forward P/E, -0.8% operating margin), whereas SNYR carries 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin). Composite vs. Pillar Nuance: While SNYR currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. INEO 41.3/100 SELL), INEO captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-0.8% vs. -10.3% operating margin) and revenue trajectory (-16.2% vs. -32.8% YoY). Technical & Structure Timing Caution: INEO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.0); meanwhile SNYR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
INEO leads the Growth & Scale pillar: INEO posts -16.2% YoY revenue growth and +12.8% YoY earnings growth on $53M TTM revenue (20.1% gross margin, -0.8% operating margin), compared with SNYR at -32.8% YoY revenue growth and -90.6% YoY earnings growth on $28M TTM revenue (65.4% gross margin, -10.3% operating margin). On trailing 12-month operating scale, INEO generates $53M in USD-normalized revenue versus $28M for SNYR. In operating R&D and SG&A reinvestment, INEO deploys 20.9% of Rev ($11M) (0 90-day corporate R&D disclosures) versus 75.7% of Rev ($21M) (0 disclosures) for SNYR.
SNYR screens cheaper on headline valuation multiples. INEO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.2x EV/Revenue (-0.0% EBITDA margin), whereas SNYR trades at 0.6x Forward P/E, 0.6x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against INEO (-4.5% ROE) versus SNYR (-361.1% ROE) capital efficiency.
In options market volatility and institutional positioning, INEO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.03β · 76% Vol realized risk). By comparison, SNYR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.86β · 868% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.